Literature DB >> 22933015

Triggered in situ drug supersaturation and hydrophilic matrix self-assembly.

F Benaouda1, M B Brown, G P Martin, S A Jones.   

Abstract

PURPOSE: To understand in situ drug thermodynamic activity when embedded in a supramolecular structured hydrophilic matrix that simultaneously self-assembled during drug supersaturation.
METHODS: A propylene glycol (PG)/water, hydroxypropyl methyl cellulose matrix containing ethanol was used to support diclofenac supersaturation. Phase behaviour, thermodynamics and drug transport were assessed through the determination of evaporation kinetics, supersaturation kinetics and transmembrane penetration.
RESULTS: Initial ethanol evaporation from the drug loaded matrix (2.9 ± 0.4 mg.min(-1).cm(-2)) was comparable to that of the pure solvent (ca. 3 mg.min(-1).cm(-2)). When 25% w/w of the total ethanol from the applied phase was lost (ethanol/water/PG molar ratio of 7:5:1.2), an inflection point in the evaporation profile and a sudden decrease in drug solubility demonstrated that a defined supramolecular structure was formed. The 55-fold decrease in drug solubility observed over the subsequent 8 h drove in situ supersaturation, the rate of which was a function of the drug load in the matrix (y = 0.0078x, R(2) < 0.99).
CONCLUSION: The self-assembling supramolecular matrix prevented drug re-crystallisation for >24 h, but did not hinder mobility and this allowed the thermodynamic activity of the drug to be directly translated into highly efficient transmembrane penetration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22933015     DOI: 10.1007/s11095-012-0838-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Impact of antinucleants on transdermal delivery of testosterone from a spray.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

2.  Relationship between the evaporation rate and vapor pressure of moderately and highly volatile chemicals.

Authors:  Ian van Wesenbeeck; Jeffrey Driver; John Ross
Journal:  Bull Environ Contam Toxicol       Date:  2008-03-18       Impact factor: 2.151

3.  Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin.

Authors:  F P Schwarb; G Imanidis; E W Smith; J M Haigh; C Surber
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

4.  Enhancement of transdermal testosterone delivery by supersaturation.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  J Pharm Sci       Date:  2006-11       Impact factor: 3.534

5.  Solubility of organic solutes in ethanol/water mixtures.

Authors:  A Li; S H Yalkowsky
Journal:  J Pharm Sci       Date:  1994-12       Impact factor: 3.534

6.  Discriminating the molecular identity and function of discrete supramolecular structures in topical pharmaceutical formulations.

Authors:  F Benaouda; M B Brown; S Ganguly; S A Jones; G P Martin
Journal:  Mol Pharm       Date:  2012-08-02       Impact factor: 4.939

7.  Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate.

Authors:  S L Raghavan; A Trividic; A F Davis; J Hadgraft
Journal:  Int J Pharm       Date:  2000-01-05       Impact factor: 5.875

8.  Manipulation of corticosteroid release from a transiently supersaturated topical metered dose aerosol using a residual miscible co-solvent.

Authors:  Monica L Reid; Marc B Brown; Stuart A Jones
Journal:  Pharm Res       Date:  2008-07-31       Impact factor: 4.200

9.  Solubility of nonelectrolytes in polar solvents IV: nonpolar drugs in mixed solvents.

Authors:  S H Yalkowsky; S C Valvani; G L Amidon
Journal:  J Pharm Sci       Date:  1976-10       Impact factor: 3.534

10.  Transient drug supersaturation kinetics of beclomethasone dipropionate in rapidly drying films.

Authors:  Monica L Reid; Stuart A Jones; Marc B Brown
Journal:  Int J Pharm       Date:  2008-12-27       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.